Purple Biotech Ltd

詳細情報 Purple Biotech Ltd 企業名

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

企業情報

企業コードPPBT

会社名Purple Biotech Ltd

上場日Sep 03, 1978

設立日1968

最高経営責任者「CEO」Mr. Gil Efron, CPA

従業員数9

証券種類Ordinary Share

決算期末Sep 03

本社所在地4 Oppenheimer St.

都市REHOVOT

証券取引所Tel Aviv Stock Exchange

国Israel

郵便番号7670104

電話番号97239333121

ウェブサイトhttps://purple-biotech.com/

企業コードPPBT

上場日Sep 03, 1978

設立日1968

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Steven Steinberg

Independent Director

--

Mr. Avraham Ben-Tzvi

General Counsel, Secretary

--

Mr. Yisrael Gewirtz

Internal Auditor

--

Dr. Eric K. Rowinsky, M.D.

Chairman of the Board

--

Mr. Gil Efron, CPA

Chief Executive Officer

--

Mr. Itzhak Israel

Director

--

Dr. Bertrand Liang

Chief Medical Officer

--

Mr. Arie Weber

Independent Director

--

Ms. Revital Stern-Raff

Independent Director

--

Dr. Hadas Reuveni

Founder and Chief Technology Officer of TyrNovo (a subsidiary)

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Steven Steinberg

Independent Director

--

Mr. Avraham Ben-Tzvi

General Counsel, Secretary

--

Mr. Yisrael Gewirtz

Internal Auditor

--

Dr. Eric K. Rowinsky, M.D.

Chairman of the Board

--

Mr. Gil Efron, CPA

Chief Executive Officer

--

Mr. Itzhak Israel

Director

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Tue, Jul 15

株主統計

種類

株主統計

比率

UBS Financial Services, Inc.

0.81%

Kingswood Wealth Advisors, LLC

0.59%

BNP Paribas Securities Corp. North America

0.19%

Morgan Stanley & Co. LLC

0.16%

GAMMA Investing LLC

0.16%

Other

98.10%

株主統計

比率

UBS Financial Services, Inc.

0.81%

Kingswood Wealth Advisors, LLC

0.59%

BNP Paribas Securities Corp. North America

0.19%

Morgan Stanley & Co. LLC

0.16%

GAMMA Investing LLC

0.16%

Other

98.10%

種類

株主統計

比率

Investment Advisor

1.44%

Research Firm

0.35%

Investment Advisor/Hedge Fund

0.16%

Other

98.06%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

36

50.71K

1.79%

-206.29K

2025Q1

39

103.31K

6.70%

-153.87K

2024Q4

41

133.07K

5.02%

-58.34K

2024Q3

39

222.98K

11.78%

+111.64K

2024Q2

39

147.98K

8.71%

+1.90K

2024Q1

40

184.47K

11.90%

+40.99K

2023Q4

40

174.27K

11.63%

+106.33K

2023Q3

38

64.91K

3.14%

-5.47K

2023Q2

37

13.88K

1.30%

-49.49K

2023Q1

37

6.26K

0.60%

-57.26K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

UBS Financial Services, Inc.

23.02K

0.81%

+12.24K

+113.53%

Mar 31, 2025

Kingswood Wealth Advisors, LLC

16.80K

0.59%

-16.80K

-50.00%

Mar 31, 2025

BNP Paribas Securities Corp. North America

5.38K

0.19%

--

Mar 31, 2025

Morgan Stanley & Co. LLC

4.46K

0.16%

-600.00

-11.85%

Mar 31, 2025

Rhumbline Advisers Ltd. Partnership

805.00

0.03%

+200.00

+33.06%

Mar 31, 2025

RBC Dominion Securities, Inc.

107.00

0%

--

Mar 31, 2025

Northwestern Mutual Capital, LLC

85.00

0%

+85.00

--

Mar 31, 2025

SBI Securities Co., Ltd.

20.00

0%

-170.00

-89.47%

Mar 31, 2025

Global Retirement Partners, LLC

16.00

0%

--

Dec 31, 2024

詳細を見る

2.330USD

Purple Biotech Ltd

2.330

概要

企業名

金融